SAN DIEGO–(BUSINESS WIRE)– #California–Biocom, the association representing the California life science industry, published a guide with comprehensive best practices for returning to work. […]
Stephen Dilly
? Momelotinib-focused Sierra Oncology, which launched a Phase III trial in November for myelofibrosis patients, has made Stephen Dilly its president and CEO, effective June 1. Dilly was previously the CEO at Aimmune from 2014 until what w… […]
Section 32 builds out high-profile team managing culture and reputation of the growing investment group […]
SAN DIEGO–(BUSINESS WIRE)—- $GOSS–Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and onco… […]
SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, will present at the Jefferies Virtual H… […]
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Icagen, a Ligand Company, announced today the expansion of Icagen’s license agreement with Roche to develop and commercialize small molecule ion channel modulators for t… […]
LA JOLLA—The Salk Institute announced that Helmsley-Salk Fellow Patrick Hsu has been named to MIT Technology Review’s prestigious annual list of Innovators Under 35. Every year, the media company recognizes a list of exceptionally talented technologist… […]
– Positive data presented at ASCO follows announcement of Fast Track Designation granted by the FDA for onvansertib in second-line treatment of patients with KRAS-mutated mCRC- 89% overall clinical benefit achieved – objective response rate (ORR) of … […]
Target Selector(TM) platform shown to be potentially more sensitive than standard-of-care cytology in detecting mutations of brain metastases in cerebrospinal fluid
SAN DIEGO, May 29, 2020 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a leading comme… […]
Scripps Institution of Oceanography climate scientist Veerabhadran Ramanathan has long had the goal of educating and empowering “one million climate warriors” who will help society tackle the world’s greatest ex… […]
Natasha Martin’s heart stopped when she first saw a photo from Wuhan, China, depicting a huge hospital ward of patients on ventilators—all unable to breathe on their own due to an unusual pneumonia caused by a n… […]
Words and formulas on a chalkboard in a large lecture hall have become digital annotations on a shared computer screen. And group discussions among students in a classroom have transitioned into breakout rooms o… […]
Company Focused on Finding an Effective Solution for Acute Kidney Injury (AKI)
CARLSBAD, Calif., May 28, 2020 /PRNewswire/ — Venture.co Brokerage Services, LLC (“VENTURE.co”) today announces a private capital investment opportunity into HemaFlo Ther… […]
SAN DIEGO, May 28, 2020 /PRNewswire/ — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $50.00 per share. All of the share… […]
– The U.S. Food and Drug Administration reviewed the Company’s request for Fast Track designation and concluded that investigation of onvansertib, in combination with FOLFIRI/bevacizumab, for second-line treatment of patients with KRAS-mutated metasta… […]
SAN DIEGO, May 28, 2020 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will be participating in the following investor conferences:
Jefferies Virtual Healthcar… […]
Michael Heltzen is the CEO of Cardea Bio. He envisions a time when biology is part of the technology. What exactly does that mean? We currently use aspects of biology to observe or manipulate living […]
The San Diego biotech will continue working to regenerate tissues throughout the body […]
PhaseBio’s clinical trial will test whether the drug helps those with severe COVID-19 survive and stay off ventilators […]
MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)—- $PHAS #ARDS–PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients […]
Ardem Patapoutian is the co-winner of the 2020 Kavli Prize in Neuroscience […]
SAN DIEGO–(BUSINESS WIRE)–Progenity, a biotechnology company with an established track record of success in developing and commercializing molecular testing products, has released four posters for the 2020 American College of Medical Genetics and Gen… […]
? La Jolla Pharmaceutical‘s shares $LJPC tumbled about 20% to $5.48 on Wednesday morning after another company — Maryland-based Amivas — was granted FDA approval for an IV formulation of an artesunate product for malaria. Artesunate is the active ingre… […]
SAN DIEGO, May 27, 2020 /PRNewswire/ — Nucleus Biologics, a leader in precision cell culture, today announced the availability of NB-Lux™, an online configuration and ordering platform for cell culture media. Designed for developers of cell therapi… […]
SAN DIEGO, May 27, 2020 /PRNewswire/ — MVPvets, a 501c(3) nonprofit organization that assists and prepares transitioning military veterans for meaningful employment in life science companies, announced the appointment of new Chairman of its Board o… […]
SAN DIEGO, May 27, 2020 /PRNewswire/ — Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing agreement w… […]
SAN DIEGO, May 27, 2020 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the com… […]
SAN DIEGO, May 26, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for its investigational new drug (IND) application for STI-6… […]
LA JOLLA—Salk Professor Gerald Joyce, a pioneer in the field of in vitro evolution, has been elected to the prestigious Royal Swedish Academy of Sciences as a foreign member. The Royal Swedish Academy’s approximately 460 Swedish and 175 foreign members… […]
Copyright © 2021 Biotech Networks, LLC
